menu Search
DCH Auriga - Healthcare
Four Star
Zuellig
GlaxoSmithKline
Ipsen

PATHEON INC

Featured products of Patheon
Cabometyx
Cabometyx FC tab 20 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Cabometyx FC tab 40 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Omjjara
Omjjara FC tab 100 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 150 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 200 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Xcopri
Xcopri tab 12.5 mg + 25 mg
cenobamate
Packing/Price
(titration pack) 28's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
Xcopri tab 50 mg
cenobamate
Packing/Price
30's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
Distributed by DCH Auriga - Healthcare
Cabometyx
Cabometyx FC tab 20 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Cabometyx FC tab 40 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Xcopri
Xcopri tab 12.5 mg + 25 mg
cenobamate
Packing/Price
(titration pack) 28's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
Xcopri tab 50 mg
cenobamate
Packing/Price
30's
MIMS Class
Anticonvulsants
ATC Classification
N03AX25 - cenobamate : Belongs to the class of other antiepileptics.
Distributed by Four Star
Cabometyx
Cabometyx FC tab 20 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Cabometyx FC tab 40 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Distributed by Zuellig
Omjjara
Omjjara FC tab 100 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 150 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 200 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Marketed by GlaxoSmithKline
Omjjara
Omjjara FC tab 100 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 150 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Omjjara FC tab 200 mg
momelotinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EJ04 - momelotinib : Belongs to the class of Janus-associated kinase (JAK) inhibitors. Used in the treatment of cancer.
Marketed by Ipsen
Cabometyx
Cabometyx FC tab 20 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.
Cabometyx FC tab 40 mg
cabozantinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EX07 - cabozantinib : Belongs to the class of other protein kinase inhibitors. Used in the treatment of cancer.

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in